Allworth Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.2M Sell
362,958
-49,306
-12% -$11.5M 0.39% 41
2026
Q1
$101M Sell
412,264
-10,960
-3% -$2.55M 0.41% 37
2025
Q4
$87.6M Buy
423,224
+41,905
+11% +$8.29M 0.36% 41
2025
Q3
$70.7M Buy
381,319
+8,640
+2% +$1.48M 0.31% 44
2025
Q2
$56.9M Buy
372,679
+43,358
+13% +$6.66M 0.27% 50
2025
Q1
$51M Buy
329,321
+5,958
+2% +$932K 0.29% 46
2024
Q4
$47M Buy
323,363
+26,459
+9% +$4.1M 0.26% 50
2024
Q3
$48.1M Buy
296,904
+7,196
+2% +$1.15M 0.29% 45
2024
Q2
$44.8M Buy
289,708
+176,209
+155% +$26.2M 0.29% 46
2024
Q1
$18M Buy
113,499
+9,189
+9% +$1.46M 0.13% 76
2023
Q4
$16.3M Sell
104,310
-3,545
-3% -$544K 0.13% 71
2023
Q3
$16.8M Sell
107,855
-7,117
-6% -$1.17M 0.14% 64
2023
Q2
$19M Buy
114,972
+5,451
+5% +$880K 0.16% 58
2023
Q1
$17M Sell
109,521
-2,174
-2% -$351K 0.17% 70
2022
Q4
$19.7M Buy
111,695
+1,422
+1% +$246K 0.22% 60
2022
Q3
$18M Buy
110,273
+30,101
+38% +$5.09M 0.23% 58
2022
Q2
$14.2M Buy
80,172
+20,206
+34% +$3.6M 0.19% 69
2022
Q1
$10.6M Buy
59,966
+26,923
+81% +$4.58M 0.14% 84
2021
Q4
$5.65M Buy
33,043
+86
+0.3% +$14.1K 0.08% 113
2021
Q3
$5.32M Buy
32,957
+2,413
+8% +$412K 0.09% 97
2021
Q2
$5.03M Sell
30,544
-2,516
-8% -$417K 0.09% 84
2021
Q1
$5.43M Buy
33,060
+10,957
+50% +$1.77M 0.11% 68
2020
Q4
$3.48M Sell
22,103
-1,248
-5% -$184K 0.09% 63
2020
Q3
$3.48M Buy
23,351
+1,303
+6% +$193K 0.1% 54
2020
Q2
$3.1M Sell
22,048
-7,549
-26% -$1.1M 0.1% 57
2020
Q1
$3.88M Buy
29,597
+10,874
+58% +$1.54M 0.13% 56
2019
Q4
$2.73M Buy
18,723
+904
+5% +$123K 0.1% 47
2019
Q3
$2.31M Sell
17,819
-1,738
-9% -$229K 0.09% 46
2019
Q2
$2.72M Sell
19,557
-781
-4% -$108K 0.11% 44
2019
Q1
$2.84M Buy
20,338
+800
+4% +$107K 0.12% 41
2018
Q4
$2.52M Buy
19,538
+988
+5% +$138K 0.12% 42
2018
Q3
$2.56M Buy
18,550
+4,134
+29% +$549K 0.12% 44
2018
Q2
$1.75M Buy
14,416
+656
+5% +$81.8K 0.08% 54
2018
Q1
$1.76M Sell
13,760
-51
-0.4% -$6.89K 0.14% 29
2017
Q4
$1.93M Buy
13,811
+1,223
+10% +$170K 0.15% 24
2017
Q3
$1.64M Sell
12,588
-220
-2% -$29.2K 0.13% 23
2017
Q2
$1.69M Buy
12,808
+999
+8% +$127K 0.15% 21
2017
Q1
$1.47M Buy
11,809
+1,520
+15% +$182K 0.14% 23
2016
Q4
$1.19M Sell
10,289
-235
-2% -$27.1K 0.12% 30
2016
Q3
$1.24M Buy
10,524
+201
+2% +$24.4K 0.13% 27
2016
Q2
$1.25M Buy
10,323
+887
+9% +$101K 0.14% 27
2016
Q1
$1.02M Buy
9,436
+277
+3% +$28.7K 0.13% 36
2015
Q4
$941K Buy
9,159
+511
+6% +$51.4K 0.17% 35
2015
Q3
$807K Sell
8,648
-290
-3% -$28.1K 0.29% 33
2015
Q2
$871K Buy
8,938
+118
+1% +$11.8K 0.31% 32
2015
Q1
$887K Buy
8,820
+316
+4% +$32.1K 0.33% 29
2014
Q4
$889K Sell
8,504
-311
-4% -$32.8K 0.34% 27
2014
Q3
$939K Buy
8,815
+36
+0.4% +$3.73K 0.37% 22
2014
Q2
$918K Buy
8,779
+40
+0.5% +$4.04K 0.41% 18
2014
Q1
$858K Sell
8,739
-34
-0.4% -$3.15K 0.38% 18
2013
Q4
$804K Buy
8,773
+314
+4% +$28.9K 0.4% 19
2013
Q3
$733K Buy
8,459
+1,261
+18% +$113K 0.38% 22
2013
Q2
$618K Buy
+7,198
New +$611K 0.35% 26

Other funds holding JNJ

Allworth Financial's JNJ Position: Q2 2026 in Review

Allworth Financial reduced its Johnson & Johnson (JNJ) stake by 12% in Q2 2026, selling an estimated $11.5M and leaving 362,958 shares worth $92.2M. The position accounts for 0.39% of the portfolio, ranked #41.

Allworth Financial first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $101M in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Allworth Financial held 362,958 shares of Johnson & Johnson worth $92.2M as of Q2 2026.
  • Allworth Financial sold 49,306 Johnson & Johnson shares in Q2 2026, an estimated $11.5M.
  • Johnson & Johnson made up 0.39% of Allworth Financial's portfolio in Q2 2026, its #41 holding.
  • Allworth Financial first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Allworth Financial's Johnson & Johnson position peaked at $101M in Q1 2026.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.